KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Neogenomics (NEO) Tax Rate (2016 - 2026)

Neogenomics filings provide 14 years of Tax Rate readings, the most recent being 2.69% for Q1 2026.

  • On a quarterly basis, Tax Rate rose 372.0% to 2.69% in Q1 2026 year-over-year; TTM through Mar 2026 was 2.92%, a 157.0% increase, with the full-year FY2025 number at 2.03%, down 38.0% from a year prior.
  • Tax Rate hit 2.69% in Q1 2026 for Neogenomics, down from 20.35% in the prior quarter.
  • In the past five years, Tax Rate ranged from a high of 20.35% in Q4 2025 to a low of 2.8% in Q3 2025.
  • Median Tax Rate over the past 5 years was 6.28% (2023), compared with a mean of 6.31%.
  • Biggest five-year swings in Tax Rate: skyrocketed 1728bps in 2022 and later crashed -1284bps in 2024.
  • Neogenomics' Tax Rate stood at 11.12% in 2022, then tumbled by -43bps to 6.28% in 2023, then decreased by -21bps to 4.99% in 2024, then skyrocketed by 308bps to 20.35% in 2025, then crashed by -87bps to 2.69% in 2026.
  • The last three reported values for Tax Rate were 2.69% (Q1 2026), 20.35% (Q4 2025), and 2.8% (Q3 2025) per Business Quant data.